Recurrent Urinary Tract Infections in Patients with Type 2 Diabetes Mellitus: A Narrative Review
Abstract
Recurrent urinary tract infections (rUTIs) represent a frequent and clinically challenging complication among patients with type 2 diabetes mellitus (T2DM). Impaired glycemic control alters host defense mechanisms, promotes glycosuria, and facilitates bacterial adhesion and colonization within the urinary tract, thereby increasing susceptibility to recurrent infections. This narrative review summarizes current evidence regarding the epidemiology, pathophysiology, microbial characteristics, diagnostic considerations, and management strategies of rUTIs in individuals with T2DM. Escherichia coli remains the predominant uropathogen; however, diabetic patients are disproportionately affected by multidrug-resistant organisms, complicating therapeutic decision-making. Autonomic neuropathy and bladder dysfunction further contribute to urinary stasis and infection recurrence. Diagnosis relies on careful clinical assessment supported by urine microscopy and culture, which is particularly important in diabetic patients to guide appropriate antimicrobial therapy. Management principles are generally similar to those applied in non-diabetic individuals but require classification of most infections as complicated, emphasizing culture-guided antibiotic selection, appropriate treatment duration, and vigilant monitoring. Non-pharmacological measures, strict glycemic control, and evaluation for structural or functional urinary tract abnormalities are essential components of care. Emerging…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.